In people with obesity, the antilipolytic actions of insulin in adipocytes together with an impaired lipid storage within these cells, leads to a rise in free fatty acids flux, systemic inflammation, and lipid accumulation in non-adipose tissues, triggering an increase in IR [92, 93]. Here, INS is linked to obesity disorder.